Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM)
Stefania Gori(Ospedale Sacro Cuore Don Calabria), Lucia Del Mastro(Ospedale Policlinico San Martino), Catia Angiolini(Azienda Ospedaliero-Universitaria Careggi), Alba Fiorentino(Ospedale Sacro Cuore Don Calabria), Michela Cinquini(Mario Negri Institute for Pharmacological Research), Laura Biganzoli(Hospital of Prato), Laura Cortesi(Azienda Ospedaliero-Universitaria di Modena), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Giovanni Pappagallo, Corrado Tinterri(Humanitas University), Fabio Puglisi(University of Udine), Andrea De Censi(Ente Ospedaliero Ospedali Galliera), Alessia Levaggi(Azienda Ospedaliera S.Maria)
Cited by 13
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k